Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
Ryan Stuchbery, Geoff Macintyre, Marek Cmero, Laurence M Harewood, Justin S Peters, Anthony J Costello, Christopher M Hovens, Niall M Corcoran
Oncotarget | IMPACT JOURNALS LLC | Published : 2016
Related Projects (1)
Investigation Of The Source Of New Testosterone Production In Prostate Tumours That Become Resistant To Existing Hormonal (Testosterone Lowering And Blocking) Therapies
Prostate cancer is critically dependent upon continued testosterone stimulation, even when the disease becomes resistant to existing hormona..
Awarded by NHMRC
This work is supported by a project grant from the NHMRC, ID: 1024081. The Australian Prostate Cancer Centre Epworth is supported by the Australian Government as represented by the Department of Health and Ageing. N.M.C. is supported by a David Bickart Clinician Research Fellowship from the Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne.